Search

Ernest Joseph Mui

age ~53

from Chicago, IL

Also known as:
  • Ernest J Mui
  • Sau Mui
Phone and address:
2727 Princeton Ave, Chicago, IL 60616
3122252469

Ernest Mui Phones & Addresses

  • 2727 Princeton Ave, Chicago, IL 60616 • 3122252469
  • 2727 S Princeton Ave APT 1, Chicago, IL 60616 • 3122252469
  • Boston, MA
  • 2727 S Princeton Ave, Chicago, IL 60616 • 3125024252

Work

  • Position:
    Installation, Maintenance, and Repair Occupations

Education

  • Degree:
    High school graduate or higher

Emails

Us Patents

  • Conjugate Constructs, Delivery, And Use For Treatment Of Disease

    view source
  • US Patent:
    8575126, Nov 5, 2013
  • Filed:
    Jun 27, 2012
  • Appl. No.:
    13/507427
  • Inventors:
    Rima McLeod - Chicago IL, US
    Bo Shiun Lai - Chicago IL, US
    William Witola - Chicago IL, US
    Kamal El Bissati - Chicago IL, US
    Ernest Mui - Chicago IL, US
    Hong Moulton - Corvallis OR, US
    Jonathan B Rothbard - Menlo Park CA, US
    Jon D Moulton - Corvallis OR, US
  • International Classification:
    C12N 15/113
    C07H 21/04
  • US Classification:
    514 44A, 536 245
  • Abstract:
    Pharmaceutical formulations of antisense peptide-conjugated phosphorodiamidate morpholino olgomers and methods of use for treatment of apicomplexan infections are disclosed. The invention is particularly directed to treatment of infections.
  • Apicomplexan Chorismate Synthase Sequences And An Inhibitor Of The Shikimate Pathway

    view source
  • US Patent:
    20030186352, Oct 2, 2003
  • Filed:
    Oct 10, 2002
  • Appl. No.:
    10/268611
  • Inventors:
    Rima McLeod - Chicago IL, US
    Michael Kirisits - Chicago IL, US
    Craig Roberts - Kirklee, GB
    Doug Mack - Centennial CO, US
    Ernest Mui - Chicago IL, US
    John Barnwell - Stone Mountain GA, US
    John Dame - Gainesville FL, US
    Jane Carlton - Rockville MD, US
    Paul Bartlett - Oakland CA, US
    Suzanna Parle - Seattle WA, US
  • International Classification:
    C12Q001/18
    C07H021/04
    C12N001/10
  • US Classification:
    435/032000, 435/258100, 536/023200
  • Abstract:
    This invention relates uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors.
  • Fab I And Inhibition Of Apicomplexan Parasites

    view source
  • US Patent:
    20040137446, Jul 15, 2004
  • Filed:
    Jun 18, 2003
  • Appl. No.:
    10/465527
  • Inventors:
    Rima McLeod - Chicago IL, US
    Stephen Muench - Stockport, GB
    John Rafferty - Sheffield, GB
    Dennis Kyle - , US
    Ernest Mui - Chicago IL, US
    Michael Kirisits - Chicago IL, US
    Douglas Mack - Centennial CO, US
    Craig Roberts - Glasgow, GB
    Benjamin Samuel - Chicago IL, US
    Russell Lyons - , US
    Wilbur Milhous - Germantown MD, US
    Sean Prigge - Severna Park MD, US
    David Rice - Sheffield, GB
  • International Classification:
    C12Q001/68
    G01N033/53
    G01N033/569
    A61K031/05
    C12N009/00
  • US Classification:
    435/006000, 435/007220, 435/183000, 514/736000
  • Abstract:
    Discovery and characterization of an apicomplexan Fab I gene and encoded enzyme and discovery of the triclosan as a lead compound, provide means to rationally design novel inhibitory compositions useful for prevention and treatment of apicomplexan related diseases.
  • Antimicrobial Agents, Diagnostic Reagents, And Vaccines Based On Unique Apicomplexan Parasite Components

    view source
  • US Patent:
    20050142113, Jun 30, 2005
  • Filed:
    Apr 14, 2004
  • Appl. No.:
    10/824194
  • Inventors:
    Rima McLeod - Chicago IL, US
    Craig Roberts - Glasgow, GB
    Fiona Roberts - Glosgow, GB
    Jennifer Johnson - Stillwater MN, US
    Michael Kirisits - Chicago IL, US
    David Ferguson - Tackley Oxford, GB
    Russell Lyons - Glasgow, GB
    Ernest Mui - Chicago IL, US
    Doug Mack - Riverside IL, US
    Benjamin Samuel - Chicago IL, US
    Piotr Gornicki - Chicago IL, US
    Ellen Zuther - Berlin, DE
  • International Classification:
    A61K048/00
    A01N063/00
    A01H005/00
  • US Classification:
    424093200
  • Abstract:
    This invention relates uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors.
  • Fab I And Inhibition Of Apicomplexan Parasites

    view source
  • US Patent:
    20090156687, Jun 18, 2009
  • Filed:
    Nov 5, 2007
  • Appl. No.:
    11/998988
  • Inventors:
    Rima McLeod - Chicago IL, US
    Michael Kirisits - Ho Chi Minh City, VN
    Dennis Kyle - Lithia FL, US
    Douglas G. Mack - Centinnel CO, US
    Wilbur Milhous - Tampa FL, US
    Stephen Muench - Leeos, GB
    Ernest J. Mui - Chicago IL, US
    Sean Prigge - Severna Park MD, US
    John Rafferty - Sheffield, GB
    David Rice - Sheffield, GB
    Craig W. Roberts - Glasgow, GB
    Benjamin Samuel - Chicago IL, US
  • International Classification:
    A61K 31/09
    C12N 9/02
    C07K 14/00
    C12Q 1/26
    C12Q 1/68
    A61P 33/02
  • US Classification:
    514717, 435189, 530350, 435 25, 435 6
  • Abstract:
    Discovery and characterization of an apicomplexan Fab I gene and encoded enzyme and discovery of the triclosan as a lead compound, provide means to rationally design novel inhibitory compositions useful for prevention and treatment of apicomplexan related diseases.
  • Vaccines Against Toxoplasma Gondii

    view source
  • US Patent:
    20130273094, Oct 17, 2013
  • Filed:
    Nov 3, 2011
  • Appl. No.:
    13/823668
  • Inventors:
    Rima McLeod - Chicago IL, US
    Tze Guan Tan - Cambridge MA, US
    Jeffery L. Alexander - San Diego CA, US
    Hua Cong - Shandong, CN
    William H. Witola - Auburn AL, US
    Kamal El Bissati - Chicago IL, US
    Ernest J. Mui - Chicago IL, US
    Steven G. Reed - Bellevue WA, US
  • Assignee:
    THE UNIVERSITY OF CHICAGO - Chicago IL
    PAXVAX, INC. - San Diego CA
    INFECTIOUS DISEASE RESEARCH INSTITUTE - Seattle WA
  • International Classification:
    A61K 39/002
  • US Classification:
    4241911
  • Abstract:
    Vaccines are disclosed against parasites. The vaccines include peptides in an immunological composition. In particular, the parasite is
  • Antimicrobial Agents, Diagnostic Reagents, And Vaccines Based On Unique Apicomplexan Parasite Components

    view source
  • US Patent:
    6737237, May 18, 2004
  • Filed:
    Aug 3, 2000
  • Appl. No.:
    09/631594
  • Inventors:
    Rima L. McLeod - Chicago IL
    Craig W. Roberts - Glasgow, GB
    Fiona Roberts - Glasgow, GB
    Jennifer J. Johnson - Stillwater MN
    Michael Kirisits - Chicago IL
    David Ferguson - Tackley Oxford, GB
    Russell Lyons - Glasgow, GB
    Ernest Mui - Chicago IL
    Doug Mack - Riverside IL
    Benjamin Samuel - Chicago IL
    Piotr Gornicki - Chicago IL
    Ellen Zuther - Beuhy, DE
  • Assignee:
    Apicomplexan Therapeutics, LLC - Oak Lawn IL
  • International Classification:
    C12Q 168
  • US Classification:
    435 6, 435 72, 435 722, 435 196, 4351901, 4352542, 4353201, 435 691, 435 19, 536 237, 536 2374, 426 941, 4261851, 4262651, 4262661, 4262731
  • Abstract:
    This invention relates uses of chorismate synthase, a component components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, in assays to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on chorismate synthase and its inhibitors.

Get Report for Ernest Joseph Mui from Chicago, IL, age ~53
Control profile